An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Morgan Stanley Infrastructure Partners Completes Investment in SpecialtyCare
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Morgan Stanley Infrastructure Partners has acquired SpecialtyCare, Inc. from Kohlberg & Company, enhancing its position in the outsourced clinical services sector for hospitals. SpecialtyCare operates in over 1,200 hospitals across 46 U.S. states, providing critical services such as cardiovascular perfusion and intraoperative neuromonitoring. With a proven track record in patient care, the acquisition aims to support SpecialtyCare's growth and improve patient outcomes. MSIP manages over $16 billion in assets and pursues investments that deliver essential public services.
Positive
Acquisition strengthens MSIP's portfolio in the healthcare sector.
SpecialtyCare's extensive service network spans over 1,200 hospitals, providing significant growth potential.
MSIP manages over $16 billion in assets, indicating strong financial backing for SpecialtyCare's expansion.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Investment funds managed by Morgan Stanley Infrastructure Partners (“MSIP”), a private infrastructure team within Morgan Stanley Investment Management, announced today that they have acquired SpecialtyCare, Inc. (“SpecialtyCare” or the “Company”) from Kohlberg & Company, LLC (“Kohlberg”).
SpecialtyCare operates the leading network of outsourced clinical services to hospital operating rooms in the U.S. With 1,200+ client hospitals in 46 U.S. states, it is the leading provider of cardiovascular perfusion, extracorporeal membrane oxygenation (“ECMO”), intraoperative neuromonitoring (“IONM”), and autologous perfusion services (“ATS”). Furthermore, SpecialtyCare is a leading provider of sterile processing services, endoscopic support and surgical assistance.
“We believe that SpecialtyCare provides an essential solution to its partners in an industry with considerable tailwinds through a contracted business model. We look forward to building upon the Company’s successful track record and further supporting their growth trajectory,” said Chris Ortega, Managing Director and Head of the Americas for MSIP.
Sam Weinstein, SpecialtyCare’s CEO said, “We are thrilled to be aligned with MSIP as we continue to pursue opportunities to improve patient care outcomes and grow our impact. We believe working with MSIP can allow us to further invest in our team with a continued focus on enhancing our strong culture.”
About Morgan Stanley Infrastructure Partners
Morgan Stanley Infrastructure Partners (“MSIP”) is a leading global private infrastructure investment platform with over $16 billion in assets under management1. Founded in 2006, MSIP has invested in a diverse portfolio of over 30 investments across transport, digital infrastructure, energy transition and utilities. MSIP targets assets that provide essential public goods and services with the potential for value creation through active asset management. For further information about Morgan Stanley Infrastructure Partners, please visit www.morganstanley.com/im/infrastructurepartners.
About SpecialtyCare
With over 1,500 clinicians supporting over 500,000 procedures annually, SpecialtyCare provides high quality people, services, and technology to the operating room. More than 1,200+ hospitals and 13,500 physicians trust SpecialtyCare to help them achieve exceptional care outcomes, regulatory compliance, and financial results. By maintaining the SpecialtyCare Operative Procedural Registry (SCOPE™), the largest procedural database of its kind, SpecialtyCare identifies standards, determines benchmarks, disseminates best practices, and fosters innovations and efficiencies that improve patient outcomes. Accredited and certified by The Joint Commission, SpecialtyCare develops expertise beyond industry requirements. Customers trust SpecialtyCare’s highly trained clinicians delivering excellence in perfusion, ECMO, intraoperative neuromonitoring, neurodiagnostic services, autotransfusion, sterile processing management, surgical assist, and minimally invasive surgical support.
_________________________
1 AUM reflects assets managed by MSIP platform since inception
